Perphenazine (generic) — Trilafon (brand)
Perphenazine (generic) — Trilafon (brand)
Parents are rightly concerned about the increased use of high potency cannabis, which has been linked in several research reports to first episode psychosis. Consider the word “first” — psychosis can be a lifelong chronic condition. Many articles in this publication have highlighted the connection.
In April, the Center for Tobacco Products of the U.S. Food and Drug Administration (FDA) recently reviewed our inspection records and determined that Ram Goods LLC sells and/or distributes electronic nicotine delivery system (ENDS) products to customers in the United States.
Child and adolescent clinicians in the United States have to be paying attention to what has happened to gender medicine in the United Kingdom. The highly respected service at the Tavistock Clinic has come under intense criticism — confusing as that may be — and in April Hilary Cass released her report to the UK's National Health Service expressing concern for gender medicine, saying it is “built on shaky foundations.” Coupled with recent lawsuits against the American Academy of Pediatrics (AAP) and gender-affirming care, the standard in the United States, clinicians are left pondering their next steps. An editorial in the British Medical Journal following the release of the Cass Report gives a balanced summation. (For the report, go to Download the Final Report). The editorial is subtitled “an opportunity to unite behind evidence informed care in gender medicine.”
Osmotic Release Oral System (OROS) Methylphenidate (generic) — Concerta (brand)
The recent Federal Trade Commission (FTC) and Department of Justice (DOJ) action against Monument Inc. for selling patient data, is just the tip of the iceberg. Monument Inc. positions itself as a treatment provider (the website home page says it provides “therapy” for alcoholism) but in its extensive terms of use, it says it is not a treatment provider. And in fact, since the FTC/DOJ action this spring, Monument radically changed its website, removing the offending promise of “confidentiality” which it breached, but still selling services (lowest price $15/month).
Called the 988 Suicide and Crisis Lifeline, this three-digit number was launched more than a year ago by the Substance Abuse and Mental Health Services Administration (SAMHSA) to great fanfare. It appeared to everyone to be mainly for suicide prevention. But it is in fact for every crisis, and substance use is included.